(6Z,13Z)-5,7,12,14-tetramethyl-1,4,8,11-tetrazacyclotetradeca-4,6,11,13-tetraene

C14H24N4 — CID 10890274

IUPAC(6Z,13Z)-5,7,12,14-tetramethyl-1,4,8,11-tetrazacyclotetradeca-4,6,11,13-tetraene
SMILESC/C1=C/C(C)=N/CCN/C(C)=C\C(C)=N\CCN1
InChIInChI=1S/C14H24N4/c1-11-9-12(2)16-7-8-18-14(4)10-13(3)17-6-5-15-11/h9-10,15,18H,5-8H2,1-4H3/b11-9-,14-10-,16-12+,17-13+
InChIKeyPVDLWZZCIHGHSJ-QTOIVACWSA-N
MW248.37 g/mol
LogP1.91
Rot. Bonds

About (6Z,13Z)-5,7,12,14-tetramethyl-1,4,8,11-tetrazacyclotetradeca-4,6,11,13-tetraene

(6Z,13Z)-5,7,12,14-tetramethyl-1,4,8,11-tetrazacyclotetradeca-4,6,11,13-tetraene (PubChem CID 10890274) has the molecular formula C14H24N4 and a molecular weight of 248.37 g/mol. Its IUPAC name is (6Z,13Z)-5,7,12,14-tetramethyl-1,4,8,11-tetrazacyclotetradeca-4,6,11,13-tetraene.

Molecular Properties

Compound Name(6Z,13Z)-5,7,12,14-tetramethyl-1,4,8,11-tetrazacyclotetradeca-4,6,11,13-tetraene
PubChem CID10890274
Molecular FormulaC14H24N4
Molecular Weight248.37 g/mol
Exact Mass248.20
IUPAC Name(6Z,13Z)-5,7,12,14-tetramethyl-1,4,8,11-tetrazacyclotetradeca-4,6,11,13-tetraene
SMILESC/C1=C/C(C)=N/CCN/C(C)=C\C(C)=N\CCN1
InChIInChI=1S/C14H24N4/c1-11-9-12(2)16-7-8-18-14(4)10-13(3)17-6-5-15-11/h9-10,15,18H,5-8H2,1-4H3/b11-9-,14-10-,16-12+,17-13+
InChIKeyPVDLWZZCIHGHSJ-QTOIVACWSA-N
XLogP1.91
TPSA48.78 Ų
H-Bond Donors2
H-Bond Acceptors4
Rotatable Bonds
Heavy Atoms18
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500248.37
LogP ≤ 51.91
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 104

Analyze (6Z,13Z)-5,7,12,14-tetramethyl-1,4,8,11-tetrazacyclotetradeca-4,6,11,13-tetraene with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

5,7-Dimethyl-2,3-dihydro-1H-[1,4]diazepine
CID 81731
(4E)-N-(Propan-2-yl)-4-[(propan-2-yl)imino]pent-2-en-2-amine
CID 71353734
2-(Methylamino)-4-(methylimino)-pentene-2
CID 14983634
(Z)-N-ethyl-4-ethyliminopent-2-en-2-amine
CID 22857106
(Z)-N-(2-methylpropyl)-4-(2-methylpropylimino)pent-2-en-2-amine
CID 49804015
N-Methyl-4-(methylimino)-2-penten-2-amine
CID 72320248
(Z)-N-propan-2-yl-4-propan-2-yliminopent-2-en-2-amine
CID 102023638
(Z)-N-propyl-4-propyliminopent-2-en-2-amine
CID 102026407
(E)-4-fluoro-N-[(Z)-1-piperazin-1-ylprop-1-en-2-yl]pent-3-en-2-imine
CID 123842165
N-[(Z)-4-[2-(diethylamino)ethylimino]pent-2-en-2-yl]-N',N'-diethylethane-1,2-diamine
CID 15960143
(Z)-N-prop-2-enyl-4-prop-2-enyliminopent-2-en-2-amine
CID 25137124
8-Dihydro-2,4,9,11-tetramethyl-1,5,8,12-tetraazacyclotetradeca-1,3,9,11-tetraene
CID 129657710

Frequently Asked Questions

What is the IUPAC name of (6Z,13Z)-5,7,12,14-tetramethyl-1,4,8,11-tetrazacyclotetradeca-4,6,11,13-tetraene?
The IUPAC name of (6Z,13Z)-5,7,12,14-tetramethyl-1,4,8,11-tetrazacyclotetradeca-4,6,11,13-tetraene (CID 10890274) is (6Z,13Z)-5,7,12,14-tetramethyl-1,4,8,11-tetrazacyclotetradeca-4,6,11,13-tetraene.
What is the SMILES notation for (6Z,13Z)-5,7,12,14-tetramethyl-1,4,8,11-tetrazacyclotetradeca-4,6,11,13-tetraene?
The canonical SMILES for (6Z,13Z)-5,7,12,14-tetramethyl-1,4,8,11-tetrazacyclotetradeca-4,6,11,13-tetraene is C/C1=C/C(C)=N/CCN/C(C)=C\C(C)=N\CCN1.
What is the InChIKey of (6Z,13Z)-5,7,12,14-tetramethyl-1,4,8,11-tetrazacyclotetradeca-4,6,11,13-tetraene?
The InChIKey is PVDLWZZCIHGHSJ-QTOIVACWSA-N. The full InChI is InChI=1S/C14H24N4/c1-11-9-12(2)16-7-8-18-14(4)10-13(3)17-6-5-15-11/h9-10,15,18H,5-8H2,1-4H3/b11-9-,14-10-,16-12+,17-13+.
What are the key properties of (6Z,13Z)-5,7,12,14-tetramethyl-1,4,8,11-tetrazacyclotetradeca-4,6,11,13-tetraene?
(6Z,13Z)-5,7,12,14-tetramethyl-1,4,8,11-tetrazacyclotetradeca-4,6,11,13-tetraene has a molecular weight of 248.37 g/mol, XLogP of 1.91, 0 rotatable bonds, 2 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for (6Z,13Z)-5,7,12,14-tetramethyl-1,4,8,11-tetrazacyclotetradeca-4,6,11,13-tetraene is sourced from PubChem (CID 10890274), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).